
Employee Benefit News - Generics pipeline grows wider
November 19th, 2008 Key Dynamics Shaping Market:
* Drug treatment costs decline in major therapy areas
* Shift in growth from top seven markets to emerging markets, and from primary care to specialty care
* Increased uncertainty over safety, pricing and market access, and intellectual property issues
NORWALK, Conn….
OB/GYN News - Drugs, Pregnancy, and Lactation - Antiepileptics
November 13th, 2008 An estimated 0.5%-2% of pregnant women are on antiepileptic medication. Most experts would agree that medical treatment of seizures cannot be stopped during pregnancy because of the high risks to the fetus if the mother has a seizure. The problem is that most first-line antiepileptic drugs have been associated with some degree of fetal risk, although the vast majority of exposed fetuses are not affected.
Some studies suggest epilepsy itself is associated with a higher risk of …
American Family Physician - Are opioids effective in the treatment of neuropathic pain?
November 8th, 2008 Cohrane Abstract
Content not available due to copyright restrictions.
Clinical Scenario
A 70-year-old woman with poorly controlled type 2 diabetes presents with burning, bilateral pain in her legs that is worsening; she requests medication to relieve he…
Medical Marketing and Media - More blockbusters exit as Fosamax, Advair go off-patent
November 2nd, 2008MERCK PUT Fosamax (alendronate sodium) and its $3 billion in total 2007 sales in its rear-view mirror last month, following the lapse of patent protection on the osteoporosis drug.
Merck forecast that 2008 sales will decline by at least half that, followed by more attrition later. Fosamax is part of about $20 billion worth of drugs expected to lose patent pr…
Medical Marketing and Media - CME REPORT: Update
October 31st, 2008NOVARTIS DECLINED comment on reports in the advertising trades that it has selected four agencies to handle its advertising business.
A story in Advertising Age noted that the company had chosen three pairs of agencies, including Omnicom Group shops DDB and Cline Davis & Mann and Interp…
Medical Marketing and Media - One to One names life sciences head
October 29th, 2008DIGITAL MARKETING firm One to One Interactive has named Gayatri Bhalla group director of its life sciences division.
In her new role, Bhalla will be responsible for the strategic direction of the life science practice, which…
The Ongoing Bipolar Money Saga
October 26th, 2008Money Problems are something that I am finding several sufferers of bipolar experience. I find this the perfect topic to be exploring on Barely Bipolar because it affects so many people in such a profound way.
This post is prompted by one of my biggest problems that I have faced as an adult. Being in the midst of economic ruin, and at a young age, I feel the need to call up this issue …
Clinical Psychiatry News - Top 10 drugs prescribed by psychiatrists in 2005.(Statistical table)(Brief article)
October 23rd, 2008Top 10 Drugs Prescribed by Psychiatrists in 2005
Millions
Lexapro 4,893
Zoloft 4,671
Seroquel 4,232
Effexor XR 4,032
Risperdal 3,493
Wellbutrin XL 3,379
Adderall XR 2,759
Ambien …
Related Results
…
Medical Marketing and Media - Draftfcb Healthcare merges two of its shops
October 19th, 2008PROJECT X-RAY and Area 23, two Manhattan agencies that spun out of Interpublic Group’s Draftfcb Healthcare unit last year, are merging.
Project X-Ray, which handled several Pfizer accounts, will be absorbed by Area 23…
Clinical Chemistry - Inter-laboratory Comparison of Serum Lamotrigine Methods
October 13th, 2008B-102
J. C. Rilchie1, D. Berry;. K. Dugaw3. G McMillin4. J. Wilson5. 1 Emory University Atlanta. GA. 2 Medical Toxicology Unit. London. United Kingdom. 3 Children’s Hospital & Regional Medical Center, Seattle. WA, 4 ARLP Laboratories. Salt Lake On; UT. 5 William Beaumont Hospital. Detroit, Ml.
Objective: To assess the inter-laboratory variability in the measurement of serum Lamotrigine (L…

